Adirondack Trust Company’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-55
| Closed | -$9.11K | – | 496 |
|
|
2023
Q2 | $9.11K | Hold |
55
| – | – | ﹤0.01% | 343 |
|
|
2023
Q1 | $5K | Hold |
55
| – | – | ﹤0.01% | 400 |
|
|
2022
Q4 | $2.09K | Hold |
55
| – | – | ﹤0.01% | 444 |
|
|
2022
Q3 | $1K | Hold |
55
| – | – | ﹤0.01% | 473 |
|
|
2022
Q2 | $2K | Hold |
55
| – | – | ﹤0.01% | 430 |
|
|
2022
Q1 | $2K | Hold |
55
| – | – | ﹤0.01% | 411 |
|
|
2021
Q4 | $1K | Buy |
+55
| New | +$1K | ﹤0.01% | 420 |
|